Symbols / SSKN Stock $0.13 +8.33% STRATA Skin Sciences, Inc.

Healthcare • Medical Devices • United States • PNK
SSKN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Dolev Rafaeli Ph.D.
Exch · Country PNK · United States
Market Cap 765.47K
Enterprise Value 9.13M
Income -6.26M
Sales 30.70M
FCF (ttm) -1.33M
Book/sh 0.49
Cash/sh 1.34
Employees 114
Insider 10d —
IPO Nov 03, 2005
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.10
PEG 0.03
P/S 0.02
P/B 0.26
P/C —
EV/EBITDA -5.33
EV/Sales 0.30
Quick Ratio 0.45
Current Ratio 0.58
Debt/Eq 559.42
LT Debt/Eq —
EPS (ttm) -1.35
EPS next Y -1.29
EPS Growth —
Revenue Growth -3.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-26
Earnings (prior) 2026-05-26
ROA -11.14%
ROE -158.91%
ROIC —
Gross Margin 58.25%
Oper. Margin 0.40%
Profit Margin -20.40%
Shs Outstand 5.89M
Shs Float 4.20M
Insider Own 9.97%
Instit Own 25.38%
Short Float 8.13%
Short Ratio 5.32
Short Interest 358.99K
52W High 3.86
vs 52W High -96.63%
52W Low 0.11
vs 52W Low 18.18%
Beta -0.08
Impl. Vol. —
Rel Volume 0.02
Avg Volume 21.16K
Volume 500.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.12
Price $0.13
Change 8.33%
About

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc. and changed its name to STRATA Skin Sciences, Inc. in December 2015. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.13
Latest analyst target
3. DCF / Fair value
$-4.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.13
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-02-27 init Maxim Group — → Buy $6
2023-05-16 reit CG Capital — → Outperform $4
2020-11-03 up HC Wainwright & Co. Neutral → Buy $3
2020-03-17 down HC Wainwright & Co. Buy → Neutral —
2019-12-09 init Ladenburg Thalmann — → Buy $5
2019-11-21 init Oppenheimer — → Outperform $7
2018-12-10 init Northland Capital Markets — → Outperform $7
News
RSS: Latest SSKN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-18 RUBINSTEIN SAMUEL Director — 5,000 $1.40 $7,028
2025-11-17 RUBINSTEIN SAMUEL Director — 14,094 $1.32 $18,804
2024-07-15 GEIGER URI Director and Beneficial Owner of more than 10% of a Class of Security — 230,573 $3.14 $723,999
2024-07-15 RAFAELI DOLEV Chief Executive Officer — 19,100 $3.14 $59,974
2024-07-15 ACCELMED PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security — 230,573 $3.14 $723,999
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
30.70
-8.54%
33.56
+0.61%
33.36
-7.75%
36.16
Operating Revenue
30.70
-8.54%
33.56
+0.61%
33.36
-7.75%
36.16
Cost Of Revenue
12.81
-10.63%
14.34
-3.74%
14.90
+3.50%
14.39
Reconciled Cost Of Revenue
12.81
-10.63%
14.34
-3.74%
14.90
+3.50%
14.39
Gross Profit
17.88
-6.98%
19.22
+4.12%
18.46
-15.19%
21.77
Operating Expense
23.72
-2.04%
24.21
-2.31%
24.78
-6.19%
26.42
Research And Development
0.42
-52.32%
0.88
-32.95%
1.32
+27.99%
1.03
Selling General And Administration
23.30
-0.13%
23.33
-0.59%
23.46
-7.58%
25.39
Selling And Marketing Expense
13.11
+5.48%
12.43
-4.06%
12.96
-15.33%
15.30
General And Administrative Expense
10.18
-6.53%
10.90
+3.69%
10.51
+4.17%
10.09
Other Gand A
10.18
-6.53%
10.90
+3.69%
10.51
+4.17%
10.09
Total Expenses
36.53
-5.23%
38.55
-2.85%
39.68
-2.77%
40.81
Operating Income
-5.83
-17.00%
-4.99
+21.09%
-6.32
-35.94%
-4.65
Total Operating Income As Reported
—
-9.26
-7.57%
-8.60
-85.07%
-4.65
EBITDA
0.18
+106.23%
-2.84
+15.92%
-3.38
-399.65%
1.13
Normalized EBITDA
-0.96
-167.18%
1.43
+862.57%
-0.19
-116.58%
1.13
Reconciled Depreciation
4.47
-15.83%
5.31
-10.08%
5.90
+3.76%
5.69
EBIT
-4.29
+47.36%
-8.15
+12.21%
-9.28
-103.55%
-4.56
Total Unusual Items
1.14
+126.59%
-4.27
-33.67%
-3.19
0.00
Total Unusual Items Excluding Goodwill
1.14
+126.59%
-4.27
-33.67%
-3.19
0.00
Special Income Charges
1.14
+126.59%
-4.27
-33.67%
-3.19
0.00
Other Special Charges
-1.14
—
0.91
—
Impairment Of Capital Assets
0.00
-100.00%
4.27
+86.87%
2.28
0.00
Net Income
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Pretax Income
-6.25
+39.07%
-10.26
+6.10%
-10.92
-99.09%
-5.49
Net Non Operating Interest Income Expense
-1.55
+16.94%
-1.86
-32.36%
-1.41
-68.34%
-0.84
Interest Expense Non Operating
1.96
-7.02%
2.11
+28.48%
1.64
+77.11%
0.93
Net Interest Income
-1.55
+16.94%
-1.86
-32.36%
-1.41
-68.34%
-0.84
Interest Expense
1.96
-7.02%
2.11
+28.48%
1.64
+77.11%
0.93
Interest Income Non Operating
0.41
+69.42%
0.24
+4.76%
0.23
+159.55%
0.09
Interest Income
0.41
+69.42%
0.24
+4.76%
0.23
+159.55%
0.09
Other Income Expense
1.14
+133.34%
-3.40
-6.61%
-3.19
—
Other Non Operating Income Expenses
—
0.86
—
—
Tax Provision
0.01
+107.06%
-0.17
-84.78%
-0.09
-246.03%
0.06
Tax Rate For Calcs
0.00
+1166.89%
0.00
+96.79%
0.00
-95.99%
0.00
Tax Effect Of Unusual Items
0.24
+436.91%
-0.07
-163.03%
-0.03
0.00
Net Income Including Noncontrolling Interests
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Net Income From Continuing Operation Net Minority Interest
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Net Income From Continuing And Discontinued Operation
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Net Income Continuous Operations
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Normalized Income
-7.16
-21.55%
-5.89
+23.16%
-7.66
-38.11%
-5.55
Net Income Common Stockholders
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Diluted EPS
—
-2.65
+14.52%
-3.10
-93.75%
-1.60
Basic EPS
—
-2.65
+14.52%
-3.10
-93.75%
-1.60
Basic Average Shares
—
3.81
+9.03%
3.49
+0.60%
3.47
Diluted Average Shares
—
3.81
+9.03%
3.49
+0.60%
3.47
Diluted NI Availto Com Stockholders
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Line Item Trend 2023-12-31
Total Assets
42.02
Current Assets
15.54
Cash Cash Equivalents And Short Term Investments
6.78
Cash And Cash Equivalents
6.78
Receivables
4.44
Accounts Receivable
4.44
Gross Accounts Receivable
4.66
Allowance For Doubtful Accounts Receivable
-0.22
Inventory
2.67
Raw Materials
2.19
Finished Goods
0.48
Prepaid Assets
—
Restricted Cash
1.33
Other Current Assets
0.31
Total Non Current Assets
26.47
Net PPE
12.40
Gross PPE
36.69
Accumulated Depreciation
-24.28
Properties
0.00
Machinery Furniture Equipment
0.53
Construction In Progress
3.23
Other Properties
32.72
Leases
0.20
Goodwill And Other Intangible Assets
13.84
Goodwill
6.52
Other Intangible Assets
7.32
Other Non Current Assets
0.23
Total Liabilities Net Minority Interest
29.33
Current Liabilities
12.17
Payables And Accrued Expenses
7.97
Payables
7.66
Accounts Payable
3.34
Current Accrued Expenses
0.31
Pensionand Other Post Retirement Benefit Plans Current
1.68
Total Tax Payable
4.32
Current Debt And Capital Lease Obligation
0.35
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
0.35
Current Deferred Liabilities
2.12
Current Deferred Revenue
2.12
Other Current Liabilities
0.05
Total Non Current Liabilities Net Minority Interest
17.15
Long Term Debt And Capital Lease Obligation
15.28
Long Term Debt
15.04
Long Term Capital Lease Obligation
0.24
Non Current Deferred Liabilities
0.19
Non Current Deferred Revenue
—
Non Current Deferred Taxes Liabilities
0.19
Other Non Current Liabilities
1.69
Stockholders Equity
12.69
Common Stock Equity
12.69
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
3.51
Ordinary Shares Number
3.51
Treasury Shares Number
0.00
Additional Paid In Capital
250.74
Retained Earnings
-238.06
Total Equity Gross Minority Interest
12.69
Total Capitalization
27.73
Working Capital
3.37
Invested Capital
27.73
Total Debt
15.63
Net Debt
8.26
Capital Lease Obligations
0.59
Net Tangible Assets
-1.15
Tangible Book Value
-1.15
Current Notes Payable
—
Current Provisions
0.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-2.79
-1586.17%
0.19
+136.22%
-0.52
+43.83%
-0.92
Cash Flow From Continuing Operating Activities
-2.79
-1586.17%
0.19
+136.22%
-0.52
+43.83%
-0.92
Net Income From Continuing Operations
-6.26
+37.92%
-10.09
+6.87%
-10.83
-95.17%
-5.55
Depreciation Amortization Depletion
4.47
-15.83%
5.31
-10.08%
5.90
+3.76%
5.69
Depreciation
4.47
-15.83%
5.31
-10.08%
5.90
+3.76%
5.69
Depreciation And Amortization
4.47
-15.83%
5.31
-10.08%
5.90
+3.76%
5.69
Other Non Cash Items
-0.98
-760.81%
0.15
+5.71%
0.14
-10.83%
0.16
Stock Based Compensation
0.64
+50.59%
0.43
-67.23%
1.30
-11.12%
1.47
Provisionand Write Offof Assets
0.13
+170.88%
-0.18
-65.45%
-0.11
-202.80%
0.11
Asset Impairment Charge
0.00
-100.00%
4.43
+93.96%
2.28
0.00
Deferred Tax
0.00
+100.00%
-0.19
-55.00%
-0.12
-400.00%
0.04
Deferred Income Tax
0.00
+100.00%
-0.19
-55.00%
-0.12
-400.00%
0.04
Operating Gains Losses
0.09
+87.76%
0.05
-95.01%
0.98
+1786.54%
0.05
Gain Loss On Sale Of PPE
0.09
+87.76%
0.05
-31.94%
0.07
+38.46%
0.05
Change In Working Capital
—
0.28
—
-2.88
Change In Receivables
1.00
+258.95%
-0.63
-547.52%
0.14
+112.31%
-1.15
Changes In Account Receivables
1.00
+258.95%
-0.63
-547.52%
0.14
+112.31%
-1.15
Change In Inventory
-0.29
-150.35%
0.57
-16.98%
0.69
+151.42%
-1.34
Change In Prepaid Assets
-0.25
-33.33%
-0.19
-176.83%
0.25
+321.62%
-0.11
Change In Payables And Accrued Expense
-0.90
-199.23%
0.91
+404.71%
-0.30
-135.70%
0.83
Change In Accrued Expense
-1.25
-167.13%
1.86
+1043.65%
-0.20
-186.03%
0.23
Change In Payable
0.35
+136.69%
-0.95
-854.00%
-0.10
-116.58%
0.60
Change In Account Payable
0.35
+136.69%
-0.95
-854.00%
-0.10
-116.58%
0.60
Change In Other Working Capital
-0.12
-115.79%
-0.06
+87.92%
-0.47
+26.71%
-0.64
Change In Other Current Liabilities
-0.33
-2.82%
-0.32
+15.16%
-0.38
+21.17%
-0.48
Investing Cash Flow
-1.47
+10.27%
-1.64
+67.40%
-5.02
-14.93%
-4.37
Cash Flow From Continuing Investing Activities
-1.47
+10.27%
-1.64
+67.40%
-5.02
-14.93%
-4.37
Net PPE Purchase And Sale
-1.47
+10.27%
-1.64
+67.40%
-5.02
-34.34%
-3.74
Purchase Of PPE
-1.47
+10.27%
-1.64
+67.40%
-5.02
-34.34%
-3.74
Capital Expenditure
-1.47
+10.27%
-1.64
+67.40%
-5.02
-34.34%
-3.74
Net Business Purchase And Sale
—
—
—
—
Purchase Of Business
—
—
—
—
Net Other Investing Changes
—
—
—
-0.63
Financing Cash Flow
3.58
+85.92%
1.93
-71.94%
6.86
+1472.20%
-0.50
Cash Flow From Continuing Financing Activities
3.58
+85.92%
1.93
-71.94%
6.86
+1472.20%
-0.50
Net Issuance Payments Of Debt
—
0.00
-100.00%
7.00
0.00
Issuance Of Debt
—
0.00
-100.00%
7.00
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
—
0.00
-100.00%
7.00
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
—
0.00
-100.00%
7.00
0.00
Net Common Stock Issuance
3.58
+84.20%
1.94
0.00
—
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
—
-0.02
+87.05%
-0.14
+72.20%
-0.50
Changes In Cash
-0.68
-243.19%
0.48
-63.95%
1.32
+122.85%
-5.79
Beginning Cash Position
8.60
+5.88%
8.12
+19.47%
6.79
-46.01%
12.59
End Cash Position
7.91
-7.95%
8.60
+5.88%
8.12
+19.47%
6.79
Free Cash Flow
-4.26
-194.34%
-1.45
+73.85%
-5.54
-18.84%
-4.66
Interest Paid Supplemental Data
1.81
-8.21%
1.97
+39.43%
1.42
+90.19%
0.74
Income Tax Paid Supplemental Data
—
0.02
+4.55%
0.02
+15.79%
0.02
Common Stock Issuance
3.58
+84.20%
1.94
0.00
—
Issuance Of Capital Stock
3.58
+84.20%
1.94
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category